eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Share:
Send email
Share:
abstract:
Original paper

Swertiamarin ameliorates cognitive dysfunction by improving hyperglycemia and neuroinflammation in type 2 diabetic rats via activation of the PI3K/AKT/GSK3β signaling pathway

Bingyin Tan
1
,
Li Liu
1
,
Tao Wu
1
,
Fangjie Yuan
1
,
Cheng Wang
2

  1. Department of Pharmacy, Wuhan Fourth Hospital, Wuhan 430033, China
  2. Department of Orthopedics, Wuhan Fourth Hospital, Wuhan 430033, China
Cent Eur J Immunol 2024; 49 (4)
DOI: https://doi.org/10.5114/ceji.2024.145754
Online publish date: 2024/12/12
View full text Get citation
 
PlumX metrics:
Introduction:
Diabetic encephalopathy (DE) is a central nervous complication of type 2 diabetes (T2D). Swertiamarin (SW) is a secoiridoid glycoside reported to have anti-hyperglycemic properties in T2D animal models. Nonetheless, the precise function of SW in T2D-induced DE remains unclarified.

Material and methods:
A T2D rat model was established by high-fat diet feeding plus streptozotocin injection, followed by SW administration. Fasting blood glucose and insulin levels were determined. The Morris water maze test was implemented to evaluate rat cognitive function. Hematoxylin-eosin staining was performed for hippocampal morphological observation. Hippocampal p-tau level was detected using immunofluorescence staining. ELISA was utilized to determine inflammatory cytokine production. Western blotting was performed to estimate PI3K/Akt/GSK3β signaling-related protein levels.

Results:
Swertiamarin treatment improved spatial learning and memory and reduced fasting blood glucose as well as insulin levels in T2D rats. SW ameliorated hippocampal morphological changes, reduced tau phosphorylation, and attenuated the inflammatory response in T2D rat hippocampal tissues. SW restored PI3K/Akt/GSK3β signaling in diabetic rat hippocampus.

Conclusions:
Swertiamarin exerts anti-diabetic and anti-inflammatory effects possibly by activating PI3K/Akt/GSK3β signaling, thereby ameliorating cognitive impairment in T2D rats.

keywords:

diabetes, diabetic encephalopathy, cognitive dysfunction, swertiamarin, PI3K/Akt/GSK3β
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.